Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Pharma
FDA christens Hyrnuo a first-line option for rare lung cancer
The FDA expanded Hyrnuo's indication to include first-line treatment, amping up the med's rivalry with Boehringer Ingelheim's Hernexeos.
Donavyn Coffey
Sep 9, 2026 4:33pm
Merck to lay off another 54 at New Jersey HQ
Sep 9, 2026 11:10am
Designing an agentic, future‑ready tech roadmap for emerging pharma
Brought to you by
ZS
BioMarin dishes ph. 3 results as Voxzogo expansion push underway
Sep 9, 2026 10:28am
Pharma marketers face privacy hurdles, turn to omnichannel strategies
Brought to you by
Swoop
FDA solidifies leadership posts at CDER, CBER
Sep 9, 2026 9:00am
